Stereoselective Behavior of a Novel Biodegradable Racemic Ketoprofen Injectable Implant in Rats

Sheng-Hao Wang,Li-Na Yin,Ze-Hua Liang,Si-Jie Lu,Su Zeng
DOI: https://doi.org/10.1002/chir.20453
2007-01-01
Chirality
Abstract:The stereoselectivity of release of ketoprofen (KET) enantiomers from a biodegradable injectable implant containing racemic KET (rac-KET) was investigated in vivo. A pre-column chiral derivatization RP-HPLC method was employed to assay diastereoisomeric derivatives of R- and S-KET. The rac-KET injectable implant, once injected subcutaneously in rats, produced long-lasting plasma levels of S-KET, which were always greater than those of R-KET. The difference in enantiomer concentration was to be related to stereoselective release, due to stereoselective interaction between D,L-PLG in the implant and KET enantiomers, as well as the chiral inversion of KET in vivo. The rac-KET injectable implant provided the sustained release of S-KET with effective plasma levels maintained for about 8 wk after a single injection.
What problem does this paper attempt to address?